Cell Biotech Co., Ltd. (KOSDAQ: A049960)
Health Care · Biotechnology · KR
₩15,360.00
-1.54% today · +25.2% 1Y
Cell Biotech Co., Ltd. (KOSDAQ: A049960) operates in the Biotechnology industry within the Health Care sector. The company is valued at $78.19M.
Over the last twelve months the share price has gained 25.2%, trading between 11.35K and 18.50K.
Tweenvest scores Cell Biotech Co., Ltd. across four factors: quality 89/100, value 65/100, dividend 100/100. Its strongest factor is dividend.
A049960 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $78.19M
- Revenue (TTM)
- $39.00M
- P/E
- 6.26
- EPS
- 2,454.45
- Dividend yield
- 3.91%
- Beta (5Y)
- 0.47
- 52-week high
- ₩18,500.00
- 52-week low
- ₩11,350.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.84M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioPorto A/SCPSE: BIOPOR | $79.36M | Dkr1.04 | -2.80% |
| Nordicus Partners CorporationOTCPK: NORD | $79.33M | $4.08 | +1.77% |
| Brii Biosciences LimitedSEHK: 2137 | $79.11M | HK$0.86 | -3.37% |
| Pelthos Therapeutics Inc.NYSEAM: PTHS | $78.48M | $20.29 | -1.02% |
| CORESTEMCHEMON Inc.KOSDAQ: A166480 | $77.21M | ₩2,340.00 | +1.08% |
| Heron Therapeutics, Inc.NasdaqCM: HRTX | $77.10M | $0.39 | -3.82% |
| Covalon Technologies Ltd.TSXV: COV | $76.84M | CA$4.10 | +3.27% |
| AriBioLab Co.,Ltd.KOSDAQ: A261780 | $76.79M | ₩3,685.00 | +8.06% |
Figures last refreshed Oct 11, 2026.